Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm Delivery
Status:
Completed
Trial end date:
2017-03-13
Target enrollment:
Participant gender:
Summary
Assess the efficacy of 2 Cervical Pessaries containing 6.3 g and 7.7 g micronized
progesterone for the prevention of preterm delivery, established through spontaneous birth
before gestation weeks 32 (31 weeks and 6 days) and 34 (33 weeks and 6 days), when the
pessary is inserted during weeks 16th and 24th and removed at 36 weeks and 6 days in pregnant
women at high risk of premature birth.